Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 2
A Phase II Multicenter Study of Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)
Background: Many cancers of the testicles and urinary tract are rare diseases; these are diseases that affect less than 200,000 people in the United States. I…
Adenocarcinoma of the BladderSquamous Cell Carcinoma of the BladderTesticular Germ Cell Tumors
Estimated
~$10 – $5,625
National Cancer Institute (NCI)NCT06041503
Phase 1
A Phase 1, First-in-Human, Dose Escalation and Expansion Study to Evaluate the Safety and Tolerability of XmAb541 in Advanced Solid Tumors
The primary purpose of this study is to determine whether the investigational drug XmAb541 is safe and well tolerated, and to determine an optimal and safe dos…
Ovarian CancerEndometrial CancerGerm Cell Tumor+2 more
Estimated
~$10 – $8,750
Xencor, Inc.NCT06276491
Phase II Trial of Serum Micro RNA-371 in Detecting Active Germ Cell Tumors in Patients With Suspected Regional Disease - (MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial)
This study evaluates the accuracy of blood-based biomarker testing to predict the presence of active testicular cancer.
Malignant Testicular Germ Cell Tumor
Estimated
~$10 – $750
University of Southern CaliforniaNCT06060873